71444-85-4

Basic information

• Product Name: 9,11-dihydroxy-8-methyl-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
• Synonyms: 1,2,3,10,11,11a-Hexahydro-9,11-dihydroxy-8-methyl-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one; 5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 1,2,3,10,11,11a-hexahydro-9,11-dihydroxy-8-methyl-
• CAS NO: 71444-85-4
• Molecular Formula: C₁₃H₁₆N₂O₃
• Molecular Weight: 248.2777
• Mol File: 71444-85-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 522.9°C at 760 mmHg
• Flash Point: 270.1°C
• Density: 1.42g/cm³
• Vapor Pressure: 9.2E-12mmHg at 25°C
• Refractive Index: 1.681
• CAS DataBase Reference: 9,11-dihydroxy-8-methyl-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 9,11-dihydroxy-8-methyl-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one(71444-85-4)
• EPA Substance Registry System: 9,11-dihydroxy-8-methyl-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one(71444-85-4)

Safety Data

• Hazardous Substances Data: 71444-85-4(Hazardous Substances Data)

Upstream product

• 71444-75-2 9,10-benzylidene-8-methyl-5,11-dioxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo<2,1-c><1,4>benzodiazepine 
• 82635-61-8 9-hydroxy-5,11-dioxo-8-methyl-2,3,5,10,11,11a-hexahydro-1H-pyrrolo<2,1-c><1,4>benzodiazepine 
• 100230-82-8 N-<3-(benzyloxy)-4-methyl-2-nitrobenzoyl>pyrrolidine-2-carboxaldehyde 
• 67-56-1 methanol 
• 7536-35-8 2-nitro-3-benzyloxy-4-methylbenzoyl chloride 
• 18944-39-3 ethyl 1-(3-benzyloxy-4-methyl-2-nitrobenzoyl)-L-prolinate 
• 78205-49-9 9-benzyloxy-8-methyl-5,11-dioxo-2,3,4,10,11,11a-hexahydro-1H-pyrrolo<2,1-c><1,4>benzodiazepine 
• 33305-75-8 L-proline ethyl ester monohydrochloride 

Relevant articles and documents

Synthesis and stereochemistry of carbinolamine containing pyrrolo[1,4]benzodiazepines by reductive cyclization of N-(2- nitrobenzoyl)pyrrolidine-2-carboxaldehydes

-

Pyrrolo benzodiazepine compounds

Novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds having antitumor activity, perhydro-1H-pyrrolo[2,1-C][1,4]-benzodiazepin-5,11-dione compounds which are synthetic intermediate of the former, and processes for producing these compounds.